890 related articles for article (PubMed ID: 27393009)
1. Structural effects of sprifermin in knee osteoarthritis: a post-hoc analysis on cartilage and non-cartilaginous tissue alterations in a randomized controlled trial.
Roemer FW; Aydemir A; Lohmander S; Crema MD; Marra MD; Muurahainen N; Felson DT; Eckstein F; Guermazi A
BMC Musculoskelet Disord; 2016 Jul; 17():267. PubMed ID: 27393009
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the structural effects of intra-articular sprifermin on cartilage and non-cartilaginous tissue alterations, based on sqMRI assessment over 2 years.
Roemer FW; Kraines J; Aydemir A; Wax S; Hochberg MC; Crema MD; Guermazi A
Osteoarthritis Cartilage; 2020 Sep; 28(9):1229-1234. PubMed ID: 32619609
[TBL] [Abstract][Full Text] [Related]
3. Brief report: intraarticular sprifermin not only increases cartilage thickness, but also reduces cartilage loss: location-independent post hoc analysis using magnetic resonance imaging.
Eckstein F; Wirth W; Guermazi A; Maschek S; Aydemir A
Arthritis Rheumatol; 2015 Nov; 67(11):2916-22. PubMed ID: 26138203
[TBL] [Abstract][Full Text] [Related]
4. Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial.
Lohmander LS; Hellot S; Dreher D; Krantz EF; Kruger DS; Guermazi A; Eckstein F
Arthritis Rheumatol; 2014 Jul; 66(7):1820-31. PubMed ID: 24740822
[TBL] [Abstract][Full Text] [Related]
5. Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial.
Hochberg MC; Guermazi A; Guehring H; Aydemir A; Wax S; Fleuranceau-Morel P; Reinstrup Bihlet A; Byrjalsen I; Ragnar Andersen J; Eckstein F
JAMA; 2019 Oct; 322(14):1360-1370. PubMed ID: 31593273
[TBL] [Abstract][Full Text] [Related]
6. Structural effects of intra-articular TGF-β1 in moderate to advanced knee osteoarthritis: MRI-based assessment in a randomized controlled trial.
Guermazi A; Kalsi G; Niu J; Crema MD; Copeland RO; Orlando A; Noh MJ; Roemer FW
BMC Musculoskelet Disord; 2017 Nov; 18(1):461. PubMed ID: 29145839
[TBL] [Abstract][Full Text] [Related]
7. Semiquantitative Imaging Biomarkers of Knee Osteoarthritis Progression: Data From the Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium.
Collins JE; Losina E; Nevitt MC; Roemer FW; Guermazi A; Lynch JA; Katz JN; Kent Kwoh C; Kraus VB; Hunter DJ
Arthritis Rheumatol; 2016 Oct; 68(10):2422-31. PubMed ID: 27111771
[TBL] [Abstract][Full Text] [Related]
8. Baseline radiographic osteoarthritis and semi-quantitatively assessed meniscal damage and extrusion and cartilage damage on MRI is related to quantitatively defined cartilage thickness loss in knee osteoarthritis: the Multicenter Osteoarthritis Study.
Guermazi A; Eckstein F; Hayashi D; Roemer FW; Wirth W; Yang T; Niu J; Sharma L; Nevitt MC; Lewis CE; Torner J; Felson DT
Osteoarthritis Cartilage; 2015 Dec; 23(12):2191-2198. PubMed ID: 26162806
[TBL] [Abstract][Full Text] [Related]
9. Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of location in the femorotibial joint: post-hoc analysis of a randomised, placebo-controlled phase II clinical trial.
Eckstein F; Kraines JL; Aydemir A; Wirth W; Maschek S; Hochberg MC
Ann Rheum Dis; 2020 Apr; 79(4):525-528. PubMed ID: 32098758
[TBL] [Abstract][Full Text] [Related]
10. Automated MRI assessment confirms cartilage thickness modification in patients with knee osteoarthritis: post-hoc analysis from a phase II sprifermin study.
Brett A; Bowes MA; Conaghan PG; Ladel C; Guehring H; Moreau F; Eckstein F
Osteoarthritis Cartilage; 2020 Nov; 28(11):1432-1436. PubMed ID: 32860991
[TBL] [Abstract][Full Text] [Related]
11. Semi-quantitative MRI biomarkers of knee osteoarthritis progression in the FNIH biomarkers consortium cohort - Methodologic aspects and definition of change.
Roemer FW; Guermazi A; Collins JE; Losina E; Nevitt MC; Lynch JA; Katz JN; Kwoh CK; Kraus VB; Hunter DJ
BMC Musculoskelet Disord; 2016 Nov; 17(1):466. PubMed ID: 27832771
[TBL] [Abstract][Full Text] [Related]
12. Structural tissue damage and 24-month progression of semi-quantitative MRI biomarkers of knee osteoarthritis in the IMI-APPROACH cohort.
Roemer FW; Jansen M; Marijnissen ACA; Guermazi A; Heiss R; Maschek S; Lalande A; Blanco FJ; Berenbaum F; van de Stadt LA; Kloppenburg M; Haugen IK; Ladel CH; Bacardit J; Wisser A; Eckstein F; Lafeber FPJG; Weinans HH; Wirth W
BMC Musculoskelet Disord; 2022 Nov; 23(1):988. PubMed ID: 36397054
[TBL] [Abstract][Full Text] [Related]
13. Associations Between Knee Effusion-synovitis and Joint Structural Changes in Patients with Knee Osteoarthritis.
Wang X; Jin X; Blizzard L; Antony B; Han W; Zhu Z; Cicuttini F; Wluka AE; Winzenberg T; Jones G; Ding C
J Rheumatol; 2017 Nov; 44(11):1644-1651. PubMed ID: 28864651
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of semi-quantitative MRI-based scoring systems for future knee replacement: data from the osteoarthritis initiative.
Hafezi-Nejad N; Zikria B; Eng J; Carrino JA; Demehri S
Skeletal Radiol; 2015 Nov; 44(11):1655-62. PubMed ID: 26205761
[TBL] [Abstract][Full Text] [Related]
15. The degeneration and destruction of femoral articular cartilage shows a greater degree of deterioration than that of the tibial and patellar articular cartilage in early stage knee osteoarthritis: a cross-sectional study.
Hada S; Kaneko H; Sadatsuki R; Liu L; Futami I; Kinoshita M; Yusup A; Saita Y; Takazawa Y; Ikeda H; Kaneko K; Ishijima M
Osteoarthritis Cartilage; 2014 Oct; 22(10):1583-9. PubMed ID: 25278068
[TBL] [Abstract][Full Text] [Related]
16. Risk factors associated with the loss of cartilage volume on weight-bearing areas in knee osteoarthritis patients assessed by quantitative magnetic resonance imaging: a longitudinal study.
Pelletier JP; Raynauld JP; Berthiaume MJ; Abram F; Choquette D; Haraoui B; Beary JF; Cline GA; Meyer JM; Martel-Pelletier J
Arthritis Res Ther; 2007; 9(4):R74. PubMed ID: 17672891
[TBL] [Abstract][Full Text] [Related]
17. Relation of meniscus pathology to prevalence and worsening of patellofemoral joint osteoarthritis: the Multicenter Osteoarthritis Study.
Hart HF; Crossley KM; Felson D; Jarraya M; Guermazi A; Roemer F; Lewis CE; Torner J; Nevitt M; Stefanik JJ
Osteoarthritis Cartilage; 2018 Jul; 26(7):912-919. PubMed ID: 29427724
[TBL] [Abstract][Full Text] [Related]
18. Severe radiographic knee osteoarthritis--does Kellgren and Lawrence grade 4 represent end stage disease?--the MOST study.
Guermazi A; Hayashi D; Roemer F; Felson DT; Wang K; Lynch J; Amin S; Torner J; Lewis CE; Nevitt MC
Osteoarthritis Cartilage; 2015 Sep; 23(9):1499-505. PubMed ID: 25929973
[TBL] [Abstract][Full Text] [Related]
19. A first-in-human, double-blind, randomised, placebo-controlled, dose ascending study of intra-articular rhFGF18 (sprifermin) in patients with advanced knee osteoarthritis.
Dahlberg LE; Aydemir A; Muurahainen N; Gühring H; Fredberg Edebo H; Krarup-Jensen N; Ladel CH; Jurvelin JS
Clin Exp Rheumatol; 2016; 34(3):445-50. PubMed ID: 27050139
[TBL] [Abstract][Full Text] [Related]
20. Radiographic progression of knee osteoarthritis is associated with MRI abnormalities in both the patellofemoral and tibiofemoral joint.
de Lange-Brokaar BJ; Bijsterbosch J; Kornaat PR; Yusuf E; Ioan-Facsinay A; Zuurmond AM; Kroon HM; Meulenbelt I; Bloem JL; Kloppenburg M
Osteoarthritis Cartilage; 2016 Mar; 24(3):473-9. PubMed ID: 26471210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
